BU
OGN icon

BBVA USA’s Organon & Co OGN Stock Holding History

BBVA USA’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$371K Buy
+11,314
New +$362K 0.02% 369

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBVA USA's OGN Position: Q3 2021 in Review

BBVA USA opened a new position in Organon & Co (OGN) in Q3 2021: 11,314 shares worth $371K. The stake represents 0.02% of the portfolio and ranks #369 among its holdings.

928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

  • BBVA USA held 11,314 shares of Organon & Co worth $371K as of Q3 2021.
  • Organon & Co was a new BBVA USA position in Q3 2021.
  • Organon & Co made up 0.02% of BBVA USA's portfolio in Q3 2021, its #369 holding.
  • 928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.